Evidence map›Paper›PMID 35889835›Full record

Trial reportNutrients2022

Effect of Flaxseed (

Dominika Kanikowska, Agnieszka Malińska, Agnieszka Mickiewicz, Agnieszka Zawada, Rafał Rutkowski, Krzysztof Pawlaczyk, Maki Sato, Andrzej Bręborowicz, Janusz Witowski, Katarzyna Korybalska

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Dominika KanikowskaDepartment of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0001-8433-5745
Agnieszka MalińskaDepartment of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
Agnieszka Mickiewicz1st Department of Cardiology, Medical University of Gdansk, 80-210 Gdansk, Poland.ORCID 0000-0003-1707-3807
Agnieszka ZawadaDepartment of Gastroenterology, Dietetics and Internal Diseases, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0001-6995-090X
Rafał RutkowskiDepartment of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Krzysztof PawlaczykDepartment of Internal Medicine, Nephrology and Transplantology, Poznan University of Medical Sciences, 60-355 Poznan, Poland.ORCID 0000-0001-6237-0814
Maki SatoInstitutional Research, School of Medicine, Aichi Medical University, Nagakute 480-1195, Aichi, Japan.
Andrzej BręborowiczDepartment of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Janusz WitowskiDepartment of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0002-1093-6027
Katarzyna KorybalskaDepartment of Pathophysiology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.ORCID 0000-0002-6291-0814
Poznan University of Medical Sciences · PLAichi Medical University · JPGdańsk Medical University · PL

Funding

Fundacja NUTRICIA RG-2 2015
6 · The paper itself

Abstract

contextFlaxseed has a characteristic fatty acids composition and unique phytonutrient profile that may have health-promoting properties.

objectiveThis study aimed to determine the effects of 10 weeks of supplementation with the flaxseed (28 g/day) on endothelial cells (EC) function, serum lipids and proinflammatory mediators in patients with mild and severe dyslipidaemia. MATERIALS AND

methodsEleven lean patients with severe dyslipidaemia treated with apheresis (group 1; 10 weeks treated in four phases: (i) ordinary diet, (ii) ordinary diet + flaxseed, (iii) ordinary diet (wash out), (iv) ordinary diet + placebo) and eleven obese patients with mild dyslipidaemia-not treated with apheresis (group 2; 10 weeks treated in two phases: (i) ordinary diet, (ii) low fat diet + flaxseed). Flaxseed was given blindly. Serum was collected at the end of each phase of the study. ECs were exposed in vitro to the medium supplemented with pooled serum taken from patients from both groups to detect their morphological changes using light and electron microscopy. ECs proliferation was also measured at the end of each study phase.

resultsSerum vascular endothelial growth factor was decreased after flaxseed supplementation but only in group 1. ECs proliferation was increased after flaxseed supplementation only in obese patients. ECs exposed to medium supplemented with obese patients' serum revealed the following cellular abnormalities: accumulation of lipid droplets, changes of rough endoplasmic reticulum and mitochondria, and flaxseed did not reverse observed changes. At the same time, flaxseed supplementation decreases total cholesterol in both tested groups, low-density lipoprotein cholesterol in group 1 and triglycerides in group 2.

conclusionsOur findings support the potential role of flaxseed in treating dyslipidaemia but indicate only a slight impact on endothelial cell function.

Indexed as

DyslipidemiasFlaxCholesterol, LDLDietary SupplementsDiet, Fat-RestrictedEndothelial CellsHumansObesityVascular Endothelial Growth Factor ACholesterol, LDLVascular Endothelial Growth Factor Adyslipidaemiaendothelial cellflaxseed

Identifiers

PMID35889835
PMCPMC9315791
OpenAlexW4285394202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.